Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma, Astrocytic”

2,207 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,207 results

Testing effectiveness (Phase 2)Study completedNCT02364206
What this trial is testing

Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma

Who this might be right for
Adult Glioblastoma
Centre Jean Perrin 18
Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Not applicableStudy completedNCT02261649
What this trial is testing

Impact of Cerebellar Mass Resection on Pain Processing

Who this might be right for
Cerebellar Neoplasm
Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT02709616
What this trial is testing

Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC)

Who this might be right for
Glioblastoma
Guangdong 999 Brain Hospital 10
Early research (Phase 1)Study completedNCT01975116
What this trial is testing

P28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

Who this might be right for
Teratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more
Pediatric Brain Tumor Consortium 18
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Testing effectiveness (Phase 2)Looking for participantsNCT05765812
What this trial is testing

Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III
Debiopharm International SA 116
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Not applicableUnknownNCT03225963
What this trial is testing

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Who this might be right for
Glioblastoma MultiformeAngiogenesis
Taichung Veterans General Hospital 60
Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Testing effectiveness (Phase 2)Study completedNCT00006358
What this trial is testing

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44
Early research (Phase 1)Ended earlyNCT00734526
What this trial is testing

Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT01931098
What this trial is testing

Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab

Who this might be right for
GlioblastomaGlioblastoma MultiformeGliosarcoma+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01260506
What this trial is testing

Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Vascular Biogenics Ltd. operating as VBL Therapeutics 75
Early research (Phase 1)Study completedNCT01308684
What this trial is testing

A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Hoffmann-La Roche 22
Not applicableStudy completedNCT00897663
What this trial is testing

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 56
Testing effectiveness (Phase 2)Ended earlyNCT01113463
What this trial is testing

TPI 287 in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain Cancer
M.D. Anderson Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT00782626
What this trial is testing

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Who this might be right for
GliomaLow-grade GliomaAstrocytoma
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT01285414
What this trial is testing

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Myrexis Inc. 5
Early research (Phase 1)Ended earlyNCT04002804
What this trial is testing

Immunotherapy With Autologous Tumor Lysate-Loaded Dendritic Cells In Patients With Recurrence Of Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 26
Load More Results